Literature DB >> 25204673

The association between the polymorphisms of TNF-α and non-Hodgkin lymphoma: a meta-analysis.

Yong-Qiao He1, Jin-Hong Zhu, Shao-Yi Huang, Zhuo Cui, Jing He, Wei-Hua Jia.   

Abstract

Many genetic variations in the promoter region of tumor necrosis factor alpha (TNF-α) may confer host susceptibility to cancer by influencing TNF-α expression. Nevertheless, the results remain inconclusive. The current meta-analysis was performed to investigate the association between three common TNF-α promoter polymorphisms and the risk of non-Hodgkin lymphoma (NHL). A literature search was conducted mainly from PubMed for all eligible studies. The pooled odds ratios (ORs) and corresponding 95 % confidence intervals (CIs) were used to assess the association of TNF-α polymorphisms with the risk of NHL. TNF-α -308 A allele showed a statistically significant increased risk for NHL under the homozygous (AA vs. GG, OR = 1.51, 95 % CI = 1.26-1.80) and recessive (OR = 1.47, 95 % CI = 1.23-1.75) models, respectively. The stratified analyses showed an increased risk of NHL with the presence of TNF-α -308 A allele among Africans and Caucasians, but a decreased risk among Asians. No association was observed between -238 G/A polymorphism and NHL risk either in the overall analysis or in the stratified analysis. Similarly, pooled analysis did not reveal an altered risk of NHL with -857 C/T polymorphism. Nonetheless, a statistically significant association was observed among Asians when stratified by ethnicity. Among the three genetic variations of interest, TNF-α -308 G/A polymorphism was significantly associated with the risk of NHL; neither -238 G/A nor -857 C/T polymorphism was shown to alter the overall NHL risk; however, stratified analysis by ethnicity observed a statistically significant association between -857 C/T polymorphism and the risk of NHL among Asians.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25204673     DOI: 10.1007/s13277-014-2569-6

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  70 in total

1.  The rise in incidence of lymphomas in Europe 1985-1992.

Authors:  R Cartwright; H Brincker; P M Carli; D Clayden; J W Coebergh; A Jack; R McNally; G Morgan; S de Sanjose; R Tumino; M Vornanen
Journal:  Eur J Cancer       Date:  1999-04       Impact factor: 9.162

2.  Tumor necrosis factor alpha polymorphism associated with increased susceptibility to development of adult T-cell leukemia/lymphoma in human T-lymphotropic virus type 1 carriers.

Authors:  K Tsukasaki; C W Miller; T Kubota; S Takeuchi; T Fujimoto; S Ikeda; M Tomonaga; H P Koeffler
Journal:  Cancer Res       Date:  2001-05-01       Impact factor: 12.701

Review 3.  Epidemiology and etiology of mantle cell lymphoma and other non-Hodgkin lymphoma subtypes.

Authors:  Karin E Smedby; Henrik Hjalgrim
Journal:  Semin Cancer Biol       Date:  2011-09-18       Impact factor: 15.707

4.  Association between non-Hodgkin lymphoma and haplotypes in the TNF region.

Authors:  Charlotte F Spink; Leigh J Keen; Fiona K Mensah; Graham R Law; Jeff L Bidwell; Gareth J Morgan
Journal:  Br J Haematol       Date:  2006-05       Impact factor: 6.998

5.  Human leukocyte antigen (HLA) A1-B8-DR3 (8.1) haplotype, tumor necrosis factor (TNF) G-308A, and risk of non-Hodgkin lymphoma.

Authors:  A M Abdou; X Gao; W Cozen; J R Cerhan; N Rothman; M P Martin; S Davis; M Schenk; S J Chanock; P Hartge; M Carrington; S S Wang
Journal:  Leukemia       Date:  2010-02-11       Impact factor: 11.528

6.  [Serum tumor necrosis factor-alpha levels in non-Hodgkin's lymphoma patients and its relationship to prognosis].

Authors:  D Li; G Li; B Wang
Journal:  Zhonghua Zhong Liu Za Zhi       Date:  1997-07

7.  Genetic variation in tumor necrosis factor and the nuclear factor-kappaB canonical pathway and risk of non-Hodgkin's lymphoma.

Authors:  James R Cerhan; Wen Liu-Mares; Zachary S Fredericksen; Anne J Novak; Julie M Cunningham; Neil E Kay; Ahmet Dogan; Mark Liebow; Alice H Wang; Timothy G Call; Thomas M Habermann; Stephen M Ansell; Susan L Slager
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-11       Impact factor: 4.254

8.  Cloning and characterization of human TNF alpha promoter region.

Authors:  S Takashiba; L Shapira; S Amar; T E Van Dyke
Journal:  Gene       Date:  1993-09-15       Impact factor: 3.688

9.  Tumor necrosis factor in solid tumors: increased blood levels in the metastatic disease.

Authors:  A Ardizzoia; P Lissoni; F Brivio; E Tisi; M S Perego; M G Grassi; S Pittalis; S Crispino; S Barni; G Tancini
Journal:  J Biol Regul Homeost Agents       Date:  1992 Jul-Sep       Impact factor: 1.711

Review 10.  TNF-alpha in promotion and progression of cancer.

Authors:  Frances Balkwill
Journal:  Cancer Metastasis Rev       Date:  2006-09       Impact factor: 9.264

View more
  8 in total

Review 1.  Association between MMP-12-82A/G polymorphism and cancer risk: a meta-analysis.

Authors:  Luliang Liu; Jinhuan Sun; Guolin Li; Boyu Gu; Xiaolong Wang; Huirong Chi; Fulin Guo
Journal:  Int J Clin Exp Med       Date:  2015-08-15

Review 2.  Association of the Asp312Asn and Lys751Gln polymorphisms in the XPD gene with the risk of non-Hodgkin's lymphoma: evidence from a meta-analysis.

Authors:  Shen Chen; Jin-Hong Zhu; Fang Wang; Shao-Yi Huang; Wen-Qiong Xue; Zhuo Cui; Jing He; Wei-Hua Jia
Journal:  Chin J Cancer       Date:  2015-03-05

3.  Association of IL10 -819C>T and -592C>A Polymorphisms with Non-Hodgkin Lymphoma Susceptibility: Evidence from Published Studies.

Authors:  Ting Zhang; Shang Xie; Jin-Hong Zhu; Qi-Wen Li; Jing He; Ai-Ping Zeng
Journal:  J Cancer       Date:  2015-06-11       Impact factor: 4.207

4.  Associations of PI3KR1 and mTOR polymorphisms with esophageal squamous cell carcinoma risk and gene-environment interactions in Eastern Chinese populations.

Authors:  Jinhong Zhu; Mengyun Wang; Meiling Zhu; Jin He; Jiu-Cun Wang; Li Jin; Xiao-Feng Wang; Jia-Qing Xiang; Qingyi Wei
Journal:  Sci Rep       Date:  2015-02-05       Impact factor: 4.379

Review 5.  NFKB1 -94insertion/deletion ATTG polymorphism and cancer risk: Evidence from 50 case-control studies.

Authors:  Wen Fu; Zhen-Jian Zhuo; Yung-Chang Chen; Jinhong Zhu; Zhang Zhao; Wei Jia; Jin-Hua Hu; Kai Fu; Shi-Bo Zhu; Jing He; Guo-Chang Liu
Journal:  Oncotarget       Date:  2017-02-07

Review 6.  Harnessing Tumor Necrosis Factor Alpha to Achieve Effective Cancer Immunotherapy.

Authors:  María Florencia Mercogliano; Sofía Bruni; Florencia Mauro; Patricia Virginia Elizalde; Roxana Schillaci
Journal:  Cancers (Basel)       Date:  2021-02-02       Impact factor: 6.639

7.  Association of TNF-α rs1800629 with Adult Acute B-Cell Lymphoblastic Leukemia.

Authors:  Ezeldine K Abdalhabib; Abdulrahman Algarni; Muhammad Saboor; Fehaid Alanazi; Ibrahim K Ibrahim; Ayman H Alfeel; Abdullah M Alanazi; Abdulmajeed M Alanazi; Abdulaziz M Alruwaili; Muath H Alanazi; Nahla A Alshaikh
Journal:  Genes (Basel)       Date:  2022-07-13       Impact factor: 4.141

8.  Polymorphisms in the AKT1 and AKT2 genes and oesophageal squamous cell carcinoma risk in an Eastern Chinese population.

Authors:  Jinhong Zhu; Mengyun Wang; Jing He; Meiling Zhu; Jiu-Cun Wang; Li Jin; Xiao-Feng Wang; Ya-Jun Yang; Jia-Qing Xiang; Qingyi Wei
Journal:  J Cell Mol Med       Date:  2016-02-01       Impact factor: 5.310

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.